Showing results (1-10 of 171) with videos related to
Sort By:
Pageof 18
Current Opinion in Supportive and Palliative Care|July 20, 2011
Bone effects of cancer therapies: pros and consRebecca Silbermann, G David RoodmanBonekey Reports|November 6, 2015
Mechanisms of osteolytic and osteoblastic skeletal lesionsG David Roodman, Rebecca SilbermannJournal of Bone Oncology|February 25, 2016
Myeloma bone disease: Pathophysiology and managementRebecca Silbermann, G David RoodmanBonekey Reports|August 17, 2013
Mechanisms of multiple myeloma bone diseaseDeborah L Galson, Rebecca Silbermann, G David RoodmanMolecular Cancer Research : MCR|January 26, 2017
EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast DifferentiationJuraj Adamik, Shunqian Jin, Quanhong Sun, et al.Frontiers in Endocrinology|July 17, 2018
XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the <i>Runx2</i> Gene in Pre-osteoblasts to Overcome Differentiation SuppressionJuraj Adamik, Rebecca Silbermann, Silvia Marino, et al.Annals of the New York Academy of Sciences|July 13, 2006
Regulation of osteoclast differentiationG David RoodmanJournal of Bone and Mineral Metabolism|February 4, 2010
Targeting the bone microenvironment in multiple myelomaG David RoodmanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
New potential targets for treating myeloma bone diseaseG David RoodmanPageof 18